Related Experiment Video
Updated: Jan 13, 2026

Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase
Published on: November 23, 2016
Multitarget Amaranth Peptides: ACE Inhibition, ACE2 Modulation, and Bioavailability Assessment
Agustina E Nardo1,2, Santiago E Suárez1,2, Susan F García Fillería1,3
1Laboratorio de Investigación, Desarrollo E Innovación en Proteínas Alimentarias (LIDiPA), CIDCA, La Plata, Argentina.
Two amaranth peptides, SFNLPILR and FNLPILR, show potential for lowering hypertension by inhibiting angiotensin-converting enzyme (ACE) and crossing the intestinal barrier. These findings support their development as functional foods for cardiovascular health.
Area of Science:
- Biochemistry
- Cardiovascular Science
- Food Science
Background:
- Hypertension is a primary risk factor for cardiovascular disease, significantly influenced by the renin-angiotensin system (RAS).
- Amaranth-derived peptides have been previously identified as potential renin inhibitors.
- Understanding the multitarget effects of these peptides is crucial for developing novel antihypertensive strategies.
Purpose of the Study:
- To evaluate the multitarget potential of three amaranth-derived peptides (SFNLPILR, FNLPILR, AFEDGFEWVSFK) beyond their known renin inhibitory activity.
- To assess their capacity to inhibit angiotensin-converting enzyme (ACE), modulate ACE2 activity, and determine their bioavailability.
- To explore their potential as functional food ingredients for hypertension management.
Main Methods:
- In vitro enzymatic assays to determine ACE and ACE2 inhibitory activity.
- Bioinformatic analysis to identify bioactive motifs within the peptide sequences.
- Molecular docking simulations to visualize peptide-ACE interactions.
- Caco-2 cell monolayer assays to assess intestinal barrier permeability.
Main Results:
- SFNLPILR and FNLPILR demonstrated potent inhibition of ACE (IC50 = 0.075 and 0.055 mM, respectively).
- These peptides exhibited selective or minimal modulation of ACE2 enzymatic activity.
- Bioinformatic and molecular docking analyses confirmed ACE-inhibitory motifs and interactions with catalytic residues.
- Transepithelial transport studies confirmed the ability of peptide fragments to permeate the intestinal barrier.
Conclusions:
- SFNLPILR and FNLPILR are effective multifunctional inhibitors of the renin-angiotensin system, targeting ACE.
- Their ability to cross the intestinal barrier suggests good bioavailability for oral administration.
- These peptides represent promising candidates for developing functional foods to mitigate hypertension risk through RAS modulation.
More Related Videos
09:21Inhibition of Aspergillus flavus Growth and Aflatoxin Production in Transgenic Maize Expressing the α-amylase Inhibitor from Lablab purpureus L.
Published on: February 15, 2019
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bioavailability Enhancement: Drug Permeability Enhancement
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Direct-Acting Cholinergic Agonists: Pharmacokinetics